TY - STD TI - Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2018. https://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/. Accessed 06 Dec 2018. UR - https://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/ ID - ref1 ER - TY - JOUR PY - 2007 DA - 2007// TI - Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007 JO - J Allergy Clin Immunol VL - 120 UR - https://doi.org/10.1016/j.jaci.2007.09.029 DO - 10.1016/j.jaci.2007.09.029 ID - ref2 ER - TY - JOUR AU - Ortega, H. G. AU - Liu, C. M. AU - Pavord, I. D. AU - Brusselle, G. G. AU - FitzGerald, J. M. AU - Chetta, A. PY - 2014 DA - 2014// TI - Mepolizumab treatment in patients with severe eosinophilic asthma JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1403290 DO - 10.1056/NEJMoa1403290 ID - Ortega2014 ER - TY - JOUR AU - Bel, E. H. AU - Wenzel, E. S. AU - Thompson, J. P. AU - Prazma, C. M. AU - Keene, N. O. AU - Yancey, W. S. PY - 2014 DA - 2014// TI - Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1403291 DO - 10.1056/NEJMoa1403291 ID - Bel2014 ER - TY - JOUR AU - Ortega, H. AU - Yancey, W. S. AU - Mayer, B. AU - Gunsoy, B. N. AU - Keene, N. O. AU - Bleecker, E. R. PY - 2016 DA - 2016// TI - Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies JO - Lancet Respir Med VL - 4 UR - https://doi.org/10.1016/S2213-2600(16)30031-5 DO - 10.1016/S2213-2600(16)30031-5 ID - Ortega2016 ER - TY - JOUR AU - Lugogo, N. AU - Domingo, C. AU - Chanez, P. AU - Leigh, R. AU - Gilson, J. M. AU - Price, G. R. AU - Yancey, W. S. AU - Ortega, G. H. PY - 2016 DA - 2016// TI - Long-term safety and efficacy of mepolizumab in patients with severe eosinophilic asthma: a multi-centre, open-label, phase IIIb study JO - Clin Ther VL - 38 UR - https://doi.org/10.1016/j.clinthera.2016.07.010 DO - 10.1016/j.clinthera.2016.07.010 ID - Lugogo2016 ER - TY - JOUR AU - Haldar, P. AU - Brightling, E. C. AU - Singapuri, A. AU - Hargadon, B. AU - Gupta, S. AU - Monteiro, W. PY - 2014 DA - 2014// TI - Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis JO - J Allergy Clin Immunol VL - 133 UR - https://doi.org/10.1016/j.jaci.2013.11.026 DO - 10.1016/j.jaci.2013.11.026 ID - Haldar2014 ER -